For patients who already have metabolic indications, shared decision-making is reasonable while monitoring weight, frailty and GI/pancreatobiliary risks. Advertisement "GLP1 agonists appear to have pleiotropic effects beyond diabetes and weight loss
AHAs can't penetrate past the skin's outer layer and won't unclog blockages in the same way that BHAs will
Comparative work with semaglutide (GLP-1R only) and tirzepatide (GIPR + GLP-1R) provides the field with a comprehensive map of how incremental receptor engagement reshapes downstream pharmacology across pancreatic, hepatic, adipose, and central nervous system tissues
However, buying B12 shots for weight loss purposes is a waste of money
Peng Y, Zhao Y, Chen Y, Yang Z, Zhang L, Xiao W, Yang J, Guo L, Wu Y
Not for ingestion or injection